B. Riley Has Negative View of Aspen Aerogels FY2027 Earnings

Key Points

• Analysts at B. Riley have lowered their FY2027 EPS estimate for Aspen Aerogels from $0.82 to $0.80, while the current consensus estimate is $0.17 per share.
• Recent quarterly earnings showed a report of ($0.04) EPS, beating estimates by $0.08, but a decline in revenue of 33.8% year-over-year.
• The stock currently has a market capitalization of $620.99 million and a consensus rating of "Moderate Buy" with a price target of $18.38.

Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - Stock analysts at B. Riley cut their FY2027 earnings per share estimates for shares of Aspen Aerogels in a research report issued to clients and investors on Friday, August 8th. B. Riley analyst R. Pfingst now forecasts that the construction company will post earnings of $0.80 per share for the year, down from their prior estimate of $0.82. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.17 per share.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%. The company had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. During the same quarter in the previous year, the business earned $0.21 EPS. The company's quarterly revenue was down 33.8% compared to the same quarter last year.

Other analysts also recently issued research reports about the company. Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and boosted their price objective for the stock from $7.00 to $16.00 in a research note on Monday. Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Finally, Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and a consensus price target of $19.50.

Aspen Aerogels Price Performance

Shares of ASPN traded up $0.03 during midday trading on Monday, reaching $7.09. The stock had a trading volume of 787,590 shares, compared to its average volume of 2,046,455. Aspen Aerogels has a 52 week low of $4.16 and a 52 week high of $33.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The firm's 50 day moving average price is $6.84 and its 200-day moving average price is $6.98. The company has a market capitalization of $583.52 million, a P/E ratio of -1.86 and a beta of 2.73.

Insider Activity

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 4.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC raised its position in Aspen Aerogels by 1,998.7% during the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after buying an additional 3,158 shares during the period. Nisa Investment Advisors LLC raised its position in Aspen Aerogels by 1,094.8% during the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after buying an additional 4,390 shares during the period. SBI Securities Co. Ltd. raised its position in Aspen Aerogels by 67.3% during the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock valued at $38,000 after buying an additional 2,551 shares during the period. Acadian Asset Management LLC acquired a new position in Aspen Aerogels during the first quarter valued at $43,000. Finally, Banque Cantonale Vaudoise acquired a new position in Aspen Aerogels during the first quarter valued at $45,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.